Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer
Mr. Kelly is a proven strategic CFO with significant financial, operational and commercialization leadership experienceVANCOUVER, British Columbia and BOSTON, Oct....
Neuroscience
Nikon Small World Honors 51st Annual Photomicrography Competition
Winning image of a common agricultural pest reveals the beauty and complexity of insects often overlooked in daily life MELVILLE,...
MeSpace Names Neurable as Official Research Partner to Explore How Workspace Design Impacts Cognitive Performance
Initial pilot study reveals measurable gains in cognitive performance within MeSpace DALLAS, Oct. 15, 2025 /PRNewswire/ -- MeSpace, a Hollman...
Precision Neuroscience Named to Fast Company’s Next Big Things in Tech List
Award recognizes technology breakthroughs that promise to help define the future of their industriesNEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE)...
Lindamood-Bell’s Neuroscience-Based Instruction Helps Students Achieve Gains as National Scores Drop
SAN LUIS OBISPO, Calif., Oct. 13, 2025 /PRNewswire/ -- The latest National Assessment of Educational Progress (NAEP) report, often referred to...
BioXcel Therapeutics to Ring Nasdaq Closing Bell on October 14 to Celebrate a Transformative Milestone in Neuroscience Innovation
NEW HAVEN, Conn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company pioneering the use...
Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference
Panel discussion featured at the International Society of Pain and Neuroscience (ISPN) Annual Meeting in London titled United to Conquer...
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
EINDHOVEN, the Netherlands, Oct. 13, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading...
NeuroVigil’s iBrain™ in TIME’s “Best Inventions of 2025”
iBrain™ - Copyright © 2025 NeuroVigil, Inc. All Rights Reserved. iBrain™ prototype iBrain™ with two quarters - Copyright © 2025...
Executive Wellness Retreats: Grey Matters International Announces Expansion of Neuroscience-Based Programs
Discover a neuroscience-based path to better mental health and executive well-being with Grey Matters International. Their personalized retreats combine brain...
Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer’s Disease Research
New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development. FREMONT, Calif., Oct. 9,...
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
PLEASANTON, Calif., Oct. 9, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it...
Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions
TIME Best Inventions honors extraordinary innovations changing lives DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader...
Glytec and Parkview Health Expand Diabetes and Glycemic Management Partnership Across Indiana and Ohio
Renewal of 10 facilities, Emergency Department implementation, and two new hospital expansions position Parkview for CMS readiness BOSTON, Oct. 9,...
Hemostemix Files for Ethics Approval of its Study of Vascular Dementia
Calgary, Alberta--(Newsfile Corp. - October 9, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is...
Hemostemix Files for Ethics Approval of its Study of Vascular Dementia
Calgary, Alberta--(Newsfile Corp. - October 9, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is...
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
Event to be held October 14th at 4 p.m. ESTBETHESDA, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc....
Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community
NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era...
An Era Where Meditation Becomes a Quantifiable Achievement — Japan’s First “Quantified Meditation Challenge”
TOKYO, Oct. 7, 2025 /PRNewswire/ -- Meditation entered a new era as the World Meditation League (WML), and All Here...
Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how biomarkers and digital tools are improving clinical trials in neurodegenerative diseases. Attendees will understand the...